Obesity
Objectives
Discuss the epidemiology and etiology of obesity.
Explain health risks associated with obesity.
Compare classification systems for body size.
Discuss nutritional therapy and exercise for obese patients.
Differentiate medications and surgical treatments for obesity.
Epidemiology of Obesity
40% of U.S. adults are obese.
1 in 10 children aged 2-5 are obese.
Highest obesity rates found in:
The South
Black and Hispanic populations
Lower income and less educated groups
Etiology and Pathophysiology
Complexity in processes leading to obesity.
Factors include:
Excess caloric intake
Hyperplasia and hypertrophy of adipocytes
Increased lipid storage and fat cell formation.
Classification of Body Weight and Obesity
Primary obesity: Excess calories for metabolic needs.
Secondary obesity: Due to metabolic issues, anomalies, or medications.
Genetic/Biologic Basis
Evidence of genetic susceptibility.
Key genes linked to obesity include the FTO gene, affecting appetite and caloric intake.
Physiologic Regulatory Mechanisms
Hormones like leptin (suppresses appetite) and ghrelin (increases appetite).
Consequences of obesity include insulin resistance, dyslipidemia, hypertension, and increased cancer risk.
Environmental and Psychosocial Factors
Poor food access and low physical activity are significant factors.
Food served emotional roles and social contexts can contribute to obesity.
Health Risks Associated With Obesity
Increased rates of:
Type 2 diabetes
Cardiovascular disease
Respiratory issues like sleep apnea.
Psychosocial problems include depression and social isolation.
Classification Systems for Obesity
Assessments include Body Mass Index (BMI), waist circumference, and body shape.
BMI classifications:
Underweight: BMI < 18.5 kg/m²
Normal: 18.5-24.9 kg/m²
Overweight: 25-29.9 kg/m²
Obese: > 30 kg/m²
Extremely obese: > 40 kg/m².
Treatments for Obesity
Nutritional therapy, exercise, behavior modification, and support groups.
Drug therapy options include:
Orlistat, Lorcaserin, Bupropion/Naltrexone, Phentermine/Topiramate.
Bariatric Surgery:
Criteria: BMI ≥ 40, or ≥ 35 with comorbidities.
Types include restrictive, malabsorptive, and combinations (like Roux-en-Y).
Maestro Rechargeable System: pacemaker-like device regulating appetite.
Metabolic Syndrome
Risk factors increase cardiovascular disease, stroke, and diabetes.
Diagnosed with 3+ of the following:
Waist circumference ≥ 40" (men) or 35" (women)
Triglycerides ≥ 150 mg/dL
HDL cholesterol < 40 (men) or < 50 (women)
BP ≥ 130/85 mm Hg
Fasting glucose ≥ 100 mg/dL.
Linked to insulin resistance and increased disease prevalence.